Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
Ya.P. Dovgalevskiy, L.E. Kuvshinova*, I.V. Graifer, N.V. Furman, P.Ya. Dovgalevskiy
Saratov Research Institute for Cardiology. Chernyshevskogo ul. 141, Saratov, 410028 Russia
Recent data and perspectives of antithrombotic therapy in patients with atrial fibrillation (AF) are highlighted. The main statements of current Russian and international guidelines about thromboembolic events prevention in AF patients are presented. Special attention paid to new agents for oral anticoagulation therapy, last information about their efficacy, safety and potential of application.
Key words: atrial fibrillation, antithrombotic therapy, oral anticoagulants, dabigatran, rivaroxaban, apixaban.
Rational Pharmacother. Card. 2011;7(5):628-636
*Corresponding author: l.e.kuvshinova@gmail.ru